Real R&D, not catalog resale
~30 days from brief to a custom formula, based on our preclinical and clinical work. 270+ SKUs already in-market.
EU R&D partner · Private label
30 years of integrative medicine. Made in Transylvania. Your EU R&D partner for natural supplements — in-house formulation or your formulation, every ingredient EU-verified, clinical evidence, own factories. From first formula to first shelf in 60 days.
Why Sanolabel by DVR Pharm
~30 days from brief to a custom formula, based on our preclinical and clinical work. 270+ SKUs already in-market.
Every raw material is EU-produced or certified by an EU-accredited laboratory. No unverified supply chains.
Both in Prejmer, Brașov · Transylvania. One chain of custody. One accountable partner. No outsourcing.
Published preclinical and clinical work. Formulations built to be compatible with classical medicine. Audit-proof by design.
Test a launch before you scale. 20–60% below EU industry norm MOQ. ~30-day delivery, PO to warehouse.
ISO 9001 + 22000. EU 1169/2011 end-to-end. EFSA-defensible claims only. GMP on the 2026 roadmap.
"We want your customers to come back for a second and a tenth time."
— Tudor Ilie, Founder
About Sanolabel by DVR Pharm
DVR Pharm was built over three decades by Tudor Ilie and a team of doctors, pharmacists and formulators who believed natural remedies should earn their place alongside classical medicine — not replace it. That discipline shaped a category in Romania: responsible natural remedies, scientifically validated, complementary to clinical treatment.
Our two factories in Prejmer, Brașov — Transylvania, a region shaped by centuries of German-Saxon industrial heritage — are where that discipline becomes product. No outsourcing. One chain of custody, one accountable partner. Every formula we make for a private-label partner carries the same rule: if we wouldn’t give it to our own family, we don’t ship it.
How we work
Five steps. Fixed windows. The reorder conversation starts on day one.
DAY 0
Tell us what you want to sell, in which markets, by when.
DAY 7
Dosage, fill, EFSA-defensible claims, 2–3 naming options, indicative price (±30%).
DAY 14
Physical samples shipped within a week of formula approval.
DAY 21
Contract, first PO, payment. Artwork & labeling locked.
DAY 60
30 days PO-to-delivery at MOQ. Reorder conversation already open.
What we can produce
Featured raw material
Premium drone-brood concentrate produced by ApicolScience — rich protein profile, endocrine-modulating bioactives, freeze-dried for stable encapsulation.
Proof — hero ranges
30 SKUs
Regeneration from telomers level.
In-market
Built around proprietary research on telomeric biomarkers — the longevity range with the deepest scientific dossier in our portfolio.
In-market since 2018 · 14 EU countries · clinical-grade documentation
60 SKUs
Apiphytotherapy.
In-market
Our apiphytotherapy line, built on raw materials from partner Romanian beekeeping cooperatives.
60-SKU range · pharmacy + naturopath channel · 8 years in-market
150 SKUs
Proprietary essential-oil study.
In-market
Developed from a proprietary distillation study spanning 12 plant families — our broadest range.
150 SKUs · in-house distillation · supplements + aromatherapy
30 SKUs
Adaptogenic and immune.
In-market
Adaptogenic + immune blends, dual-extracted in-house using both alcohol and water phases.
Single strains + blends · dual-extraction lab · launched 2022
Client stories
Selected partners
Logos under NDA — anonymized placeholders shown until partner approval.
"A 48-location herbal-retail chain launched a 17-SKU private-label range with us in 2023 — the range now anchors their shelf presence and triggered a second co-development cycle."
"A 52-member patronat of pharmacy networks launched their private-label line with our core SKUs as the quality anchor — consistent reorders since Q2 2023."
FAQ — buyer questions
By default, the client owns formulations developed from their brief — documented in the contract. Existing DVR ranges have explicit license terms agreed upfront, so there's no ambiguity on what's yours, what's ours, and what's licensed.
Yes. We sign a mutual NDA before any formulation brief or category exchange. We accept your template if it's reasonable; otherwise we use ours — turnaround is typically 24–48h.
Common scenario. We work from your existing formula, supplier list and label spec, then re-spec to our pipeline. Typical transition is 30–60 days, depending on formula complexity, claim documentation, and supplier handover.
EXW Brașov by default. FCA, DAP and DDP available on request. We handle EU customs documentation; you nominate the carrier or use ours. EU 1169/2011 compliant labelling end-to-end.
NDA from the first technical conversation. Per-client batch tracking, no cross-client information sharing, separate documentation. Dedicated batch isolation on production lines is available on request for sensitive launches.
2,000 pieces per SKU — 20–60% below the typical EU industry norm. This lets you test a launch in-market before scaling, instead of betting working capital on a 10,000+ unit run.
Around 60 days end-to-end: ~30 days brief to formula approval, 7 days from formula to physical samples, ~30 days from contract sign to shipment at MOQ. Reorders run on shorter windows.
Meet us in Barcelona
“Twenty minutes. We'll show samples, walk you through a formulation brief, and leave you with a price window before you leave the hall.”
Book a 20-minute slot at the stand or drop by New Exhibitor Pavilion, 4C116I · 4C116J. Bring your brief, leave with a formula direction.
Get started
Both options get you a real answer within the week — no gated sales funnel, no catalog PDF disguised as a proposal.
Calendly — pick a slot, we show up.
Open schedulerTell us what you sell and where — we ship samples within a week.
Download the full brochure — capabilities, ranges, timeline and compliance, in one PDF you can share internally.